Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-028579
Filing Date
2021-07-15
Accepted
2021-07-15 21:36:45
Documents
2
Period of Report
2021-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7113
2 EX-24 DOCUMENT attachment1.htm EX-24 5186
  Complete submission text file 0000899243-21-028579.txt   13666
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Issuer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ERASCA, INC. 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address
Chacko David M. (Reporting) CIK: 0001871801 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40602 | Film No.: 211094151